Cell separation in Neisseria gonorrhoeae
淋病奈瑟菌的细胞分离
基本信息
- 批准号:8417663
- 负责人:
- 金额:$ 22.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-05 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmidohydrolasesAnimal ModelAntibiotic ResistanceAntibiotic TherapyAntibioticsAntibodiesAutolysisBacillus subtilisBacteriaBiochemicalBiochemical ReactionBiological AssayCell FractionCell SeparationCell WallCellsCervicalCharacteristicsCombined Modality TherapyComplexDNADataDefectDetergentsDiseaseEctopic PregnancyElectron MicroscopyEnzyme Inhibitor DrugsEnzyme InhibitorsEnzyme InteractionEnzymesEscherichia coliFutureGene DeletionGenesGonorrheaGrowthHumanImmunoprecipitationIn VitroInfectionInfertilityInflammatory ResponseInvadedKnowledgeLocationLyticMeasuresMembraneMetabolismMethodsMicrotomyMulti-Drug ResistanceMutationNeisseria gonorrhoeaeNormal CellPelvic Inflammatory DiseasePeptidoglycanPopulationProcessProteinsRoleScaffolding ProteinSchemeSexually Transmitted DiseasesShapesSystemTestingTimeWestern BlottingWomanamidaseantimicrobialbasecombatdrug sensitivityin vitro Assayinhibitor/antagonistlink proteinmenmutantnovelpathogenpreventresearch studyresistant strain
项目摘要
DESCRIPTION (provided by applicant): Neisseria gonorrhoeae causes a very common sexually transmitted disease in men and women that often results in severe consequences for women including pelvic inflammatory disease, ectopic pregnancy, and infertility. The gonococcal population is becoming increasingly antibiotic resistant, and multidrug resistant strains have arisen. This proposal seeks to understand the mechanisms of peptidoglycan breakdown involved in cell separation and to develop cell separation as a target for antimicrobial therapy. Preliminary data indicate that defects in cell separation make N. gonorrhoeae more sensitive to antibiotics as well as defective in infection of human cells. Previously we demonstrated that mutations in genes for peptidoglycan degradation - amiC or ltgC - in N. gonorrhoeae cause aberrant growth, loss of cell separation, and increased autolysis. These mutants grow in large aggregates sharing a single interconnected cell wall and with a single outer membrane surrounding the aggregate. Here we will 1) determine the biochemical functions of two peptidoglycan-degrading enzymes, AmiC and LtgC, required for cell separation and develop assays that could be used to identify inhibitors of these enzymes, 2) examine the localization and possible interactions of AmiC and LtgC in gonococcal cells in order to determine the function of these enzymes for cell separation and develop assays for these enzymes in cells, and 3) determine the extent of defects of cell separation mutants for infection of human cells and for resistance to antibiotics. Knowledge gained in this study and assays developed here will facilitate the identification of antibiotics for the treatment of gonococcal diseases and for combating other bacteria that have similar mechanisms of cell separation.
描述(由申请人提供):淋病奈瑟菌在男性和女性中引起一种非常常见的性传播疾病,通常会给女性带来严重的后果,包括盆腔炎、宫外孕和不孕症。淋球菌群体对抗生素的耐药性日益增强,并且出现了多重耐药菌株。该提案旨在了解细胞分离中涉及的肽聚糖分解机制,并将细胞分离开发为抗菌治疗的目标。初步数据表明,细胞分离缺陷使淋病奈瑟菌对抗生素更加敏感,并且在感染人体细胞方面存在缺陷。之前我们证明了淋病奈瑟菌中肽聚糖降解基因(amiC 或 ltgC)的突变会导致异常生长、细胞分离丧失和自溶增加。这些突变体以大聚集体的形式生长,共享单个互连的细胞壁并具有围绕聚集体的单个外膜。在这里,我们将 1) 确定细胞分离所需的两种肽聚糖降解酶 AmiC 和 LtgC 的生化功能,并开发可用于鉴定这些酶抑制剂的检测方法,2) 检查 AmiC 和 LtgC 的定位和可能的相互作用在淋球菌细胞中,以确定这些酶在细胞分离中的功能并开发细胞中这些酶的测定方法,以及 3) 确定细胞分离缺陷的程度用于感染人类细胞和对抗生素产生耐药性的突变体。在这项研究中获得的知识和这里开发的测定将有助于鉴定用于治疗淋球菌疾病和对抗具有类似细胞分离机制的其他细菌的抗生素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph P Dillard其他文献
Published Ahead of Print 4 Peptidoglycan Fragment Release From
印刷前发布 4 肽聚糖片段发布自
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Daniel L. Garcia;Joseph P Dillard - 通讯作者:
Joseph P Dillard
Joseph P Dillard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph P Dillard', 18)}}的其他基金
Mechanisms regulating peptidoglycan fragment production
调节肽聚糖片段产生的机制
- 批准号:
9896150 - 财政年份:2020
- 资助金额:
$ 22.58万 - 项目类别:
相似国自然基金
腈水解酶的催化杂泛性机理解析及其在S-2,2-二甲基环丙烷甲酰胺合成中的应用
- 批准号:22308332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人工智能辅助进化腈水解酶合成酰胺类化合物
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于缺陷金属有机骨架的定向自组装固定化酰胺水解酶调控机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于去对称化反应的酰胺水解酶催化机制研究及定向改造
- 批准号:21977098
- 批准年份:2019
- 资助金额:66 万元
- 项目类别:面上项目
N-亚油酰酪氨酸靶向脂肪酰胺水解酶诱导神经元自噬抗AD的作用及机制研究
- 批准号:81803514
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 22.58万 - 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8912086 - 财政年份:2014
- 资助金额:
$ 22.58万 - 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8702797 - 财政年份:2014
- 资助金额:
$ 22.58万 - 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8800543 - 财政年份:2014
- 资助金额:
$ 22.58万 - 项目类别: